Shaokun Shu

机构：Peking University, Peking University Cancer Hospital, Peking University International Hospital, Advanced Cell Diagnostics (United States), Ministry of Education · ORCID：0000-0001-6839-2782

发表论文 127 篇 · 总被引 2541 次 · h-index 23

代表论文

• UDA-seq: universal droplet microfluidics-based combinatorial indexing for massive-scale multimodal single-cell sequencing (2025 · Nature Methods · 被引 49)
• Heterogeneity and transcriptional drivers of triple-negative breast cancer (2023 · Cell Reports · 被引 30)
• Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury (2025 · Nature Communications · 被引 21)
• Single-cell EpiChem jointly measures drug–chromatin binding and multimodal epigenome (2024 · Nature Methods · 被引 12)
• Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors (2026 · Science Advances · 被引 2)
• siDiff: De Novo siRNA Design via Efficacy-Guided Discrete Masked Diffusion (2026 · bioRxiv (Cold Spring Harbor Laboratory))